Trial intelligence / Profile preview

Lumiracoxib Preemptive vs Postoperative in Knee Surgery

NCT00333567Phase 4Completed

Sponsor
Novartis
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lumiracoxib in postoperative pain, sponsored by Novartis. Started Aug 2006; status: completed.

02

Drugs

lumiracoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00333567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00333567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call